UZM-35 zeolitic composition, method of preparation and processes
    77.
    发明授权
    UZM-35 zeolitic composition, method of preparation and processes 有权
    UZM-35沸石组合物,制备方法和工艺

    公开(公告)号:US08053618B1

    公开(公告)日:2011-11-08

    申请号:US13151482

    申请日:2011-06-02

    摘要: A new family of crystalline aluminosilicate zeolitic compositions, UZM-35 compositions, has been synthesized. These zeolitic compositions are represented by the empirical formula. Mmn+Rr+Al1-xExSiyOz where M represents a combination of potassium and sodium exchangeable cations, R is a singly charged organoammonium cation such as the dimethyldipropylammonium cation and E is a framework element such as gallium. These compositions comprise a MSE zeolite, a MFI zeolite and an ERI zeolite. The compositions are similar to MCM-68 but are characterized by unique x-ray diffraction patterns and have catalytic properties for carrying out various hydrocarbon conversion processes.

    摘要翻译: 已经合成了一系列结晶硅铝酸盐沸石组合物UZM-35组合物。 这些沸石组合物由经验公式表示。 Mmn + Rr + Al1-xExSiyOz其中M表示钾和钠可交换阳离子的组合,R是单电荷的有机铵阳离子,例如二甲基二丙基铵阳离子,E是骨架元素如镓。 这些组合物包含MSE沸石,MFI沸石和ERI沸石。 组合物类似于MCM-68,但其特征在于独特的x射线衍射图,并且具有用于进行各种烃转化方法的催化性能。

    Compounds for the treatment of metabolic disorders
    78.
    发明授权
    Compounds for the treatment of metabolic disorders 有权
    用于治疗代谢紊乱的化合物

    公开(公告)号:US08044243B2

    公开(公告)日:2011-10-25

    申请号:US12279247

    申请日:2007-02-09

    CPC分类号: C07C43/23

    摘要: Agents useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, polycystic ovary syndrome, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis are disclosed. Formula (I) wherein n is 1 or 2; q is 0 or 1; t is 0 or 1; R1 is alkyl having from 1 to 3 carbon atoms; R2 is hydrogen, halo, alkyl having from 1 to 3 carbon atoms, or alkoxy having from 1 to 3 carbon atoms; A is unsubstituted or substituted phenyl; or cycloalkyl; or a 5 or 6 membered heteroaromatic ring. Alternatively, the agent can be a pharmaceutically acceptable salt of the compound of Formula I.

    摘要翻译: 公开了可用于治疗各种代谢紊乱(例如胰岛素抵抗综合征,糖尿病,多囊卵巢综合征,高脂血症,脂肪肝疾病,恶病质,肥胖症,动脉粥样硬化和动脉硬化)的药剂。 式(I)其中n为1或2; q为0或1; t为0或1; R1是具有1至3个碳原子的烷基; R2是氢,卤素,具有1至3个碳原子的烷基或具有1至3个碳原子的烷氧基; A是未取代或取代的苯基; 或环烷基; 或5或6元杂芳族环。 或者,该试剂可以是式I化合物的药学上可接受的盐。

    PREPARATION OF DECAHALODIPHENYL ETHANE
    79.
    发明申请
    PREPARATION OF DECAHALODIPHENYL ETHANE 审中-公开
    十氢二苯乙烯的制备

    公开(公告)号:US20080058458A1

    公开(公告)日:2008-03-06

    申请号:US11840293

    申请日:2007-08-17

    IPC分类号: C07C25/00 C08K5/03

    CPC分类号: C09K21/08 C07C17/12 C07C25/18

    摘要: This invention provides a process of preparing reaction-derived decahalodiphenylethane of high purity. The process comprises cofeeding separate feeds of (a) diphenylethane and (b) bromine chloride, bromine chloride and bromine, or bromine chloride and chlorine to a refluxing reaction mixture comprising bromine and at least one Lewis acid bromination catalyst so that high purity decahalodiphenylethane is formed.

    摘要翻译: 本发明提供了制备高纯度的反应衍生的十氢二苯基乙烷的方法。 该方法包括将(a)二苯基乙烷和(b)溴氯化物,溴氯化物和溴或溴氯化物和氯的单独进料共进料到包含溴和至少一种路易斯酸溴化催化剂的回流反应混合物中,从而形成高纯度的十氢二苯基乙烷 。